Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis

Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis

The soluble urokinase-type plasminogen activator receptor (suPAR) has evolved as a useful biomarker for different entities of chronic liver disease. However, its role in patients with primary sclerosing cholangitis (PSC) is obscure. We analyzed plasma levels of suPAR in 84 patients with PSC and comp...

Full description

Bibliographic Details
Main Authors: Burcin Özdirik, Martin Maibier, Maria Scherf, Jule Marie Nicklaus, Josephine Frohme, Tobias Puengel, Dirk Meyer zum Büschenfelde, Frank Tacke, Tobias Mueller, Michael Sigal
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Journal of Clinical Medicine
Subjects:
primary sclerosing cholangitis
biomarkers
soluble urokinase plasminogen activator receptor
liver cirrhosis
Online Access:https://www.mdpi.com/2077-0383/11/9/2479

Internet

https://www.mdpi.com/2077-0383/11/9/2479

Similar Items